Physician
Endocrinology
Dr. Lawrence Blonde, MD
|
|
Give Review
Lawrence Blonde works in the field of Endocrinology. He went to medical school at Albany Medical College. He over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACE)". Lawrence Blonde is a published doctor. He published 87 publications, including: 'Painless subacute thyroiditis simulating Graves'' disease.'
Publications
- Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone.
- Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trials.
- Diabetes-Related Composite Quality End Point Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials.
- Effects of canagliflozin on body weight and relationship to HbA1c and blood pressure changes in patients with type 2 diabetes.
- Fixed-Dose Combination Therapy in Type 2 Diabetes Mellitus.
- Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH Insulin.
- The Role of Bromocriptine-QR in the Management of Type 2 Diabetes Expert Panel Recommendations.
- Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects.
- Achieving antihyperglycemic treatment goals with incretin-related therapies.
- Thiazolidinediones in the treatment of managed care patients with type 2 diabetes.
- New directions for type 2 diabetes mellitus management.
- Thalidomide-associated hyperglycemia and diabetes: case report and review of literature.
- Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
- Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study.
- Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, compara...
- Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes.
- Real-world trials to answer real-world questions.
- Metabolic issues in patients with severe mental illness.
- The road ahead in diabetes management.
- Best practices in diabetes management: getting more patients to goal.
- Current evidence regarding the value of self-monitored blood glucose testing.
- The Hurricane Katrina aftermath and its impact on diabetes care: observations from "ground zero": lessons in disaster preparedness of people with diabetes.
- Current challenges in diabetes management.
- ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations.
- Internet resources to improve health care for patients with diabetes.
- What are incretins, and how will they influence the management of type 2 diabetes?
- Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program.
- Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
- Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?
- State of diabetes care in the United States.
- Case presentation: a patient with type 2 diabetes.
- Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force.
- American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus.
- Easing the transition to insulin therapy in people with type 2 diabetes.
- Predicted risk of diabetes and coronary heart disease in patients with schizophrenia: aripiprazole versus standard of care.
- Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone.
- Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-...
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
- A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitus.
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan.
- American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary.
- Effective glycemic management in hospitalized patients: a multidisciplinary approach.
- Quality of care indicators, health behaviors, and physical functioning in adults with diabetes.
- Benefits and risks for intensive glycemic control in patients with diabetes mellitus.
- Improving care for patients with type 2 diabetes: applying management guidelines and algorithms, and a review of new evidence for incretin agents and lifestyle interve...
- Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes.
- Fixed-dose combinations for treatment of type 2 diabetes mellitus.
- Consensus report of the coalition for clinical research-self-monitoring of blood glucose.
- Current antihyperglycemic treatment strategies for patients with type 2 diabetes mellitus.
- Current antihyperglycemic treatment guidelines and algorithms for patients with type 2 diabetes mellitus.
- Switching to once-daily liraglutide from twice-daily exenatide further improves glycemic control in patients with type 2 diabetes using oral agents.
- What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Manag...
- Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in pa...
- The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies.
- Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial--a primary care, ty...
- Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the...
- The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera as a therape...
- Does home-based exercise improve body mass index in patients with type 2 diabetes? Results of a feasibility trial.
- Partnering with governments and other institutions: driving change in diabetes care.
- Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes.
- Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia de...
- Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy.
- Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibe...
- Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin.
- Subacute thyroiditis with increased serum alkaline phosphatase.
- Bone scan patterns of patients with diffuse metastatic carcinoma of the axial skeleton.
- Hypoglycemia: the "undisease".
- Painless subacute thyroiditis simulating Graves'' disease.
- Familial hypertension.
- High-density lipoprotein cholesterol. Recommendations for routine testing and treatment.
- Simultaneous radioimmunoassay for the measurement of adenosine 3'',5''-monophosphate and guanosine 3'',5''-monophosphate.
- Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
- Sources of cyclic nucleotides in plasma.
- Reversal of amitriptyline intoxication by physostigmine.
- American College of Physicians (ACP) medical informatics and telemedicine.
- 1997 ASP Leadership Conference: report on the status of subspecialty training.
- Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin.
- Assessing the quality of medical subspecialty training programs.
- Defining and measuring quality of diabetes care.
- Internet use by endocrinologists.
- Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia.
- Transitioning patients with type 2 diabetes to a fixed combination > glyburide/metformin tablet.
- Management of type 2 diabetes: update on new pharmacological options.
- Disease management approaches to type 2 diabetes.
- Liraglutide achieves A1C targets more often than sitagliptin or exenatide when added to metformin in patients with type 2 diabetes and a baseline A1C <8.0%.
- Current issues in GLP-1 receptor agonist therapy for type 2 diabetes.
Schools
Albany Medical College Of Union University
Albany Medical College
Albany Medical Center
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACE)
Education
-
Albany Medical Center -
Albany Medical College
Hospital
-
Ochsner Medical Center
Helpful Reviews
Similar Doctors
|
Dr. William T. Cefalu, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Samuel S. Andrews II, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Susana L. Dipp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tina K. Thethi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gabriel Uwaifo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles W. Hilton Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sadda R. Reddy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward L. Michals, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria A. Incer, MD
This Doctor is OpenDoctor Recommended.
|